University of Hertfordshire

Approaches to the Development and Use of PRO Measures: A New Roadmap

Research output: Chapter in Book/Report/Conference proceedingChapter

Standard

Approaches to the Development and Use of PRO Measures: A New Roadmap. / Kamudoni, Paul; Johns, Nutjaree; Salek, Mir-Saeed Shayegan.

Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Singapore : Adis, 2018. p. 15-49.

Research output: Chapter in Book/Report/Conference proceedingChapter

Harvard

Kamudoni, P, Johns, N & Salek, M-SS 2018, Approaches to the Development and Use of PRO Measures: A New Roadmap. in Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Adis, Singapore, pp. 15-49. https://doi.org/10.1007/978-981-10-8414-0_2

APA

Kamudoni, P., Johns, N., & Salek, M-S. S. (2018). Approaches to the Development and Use of PRO Measures: A New Roadmap. In Living with Chronic Disease: Measuring Important Patient-Reported Outcomes (pp. 15-49). Adis. https://doi.org/10.1007/978-981-10-8414-0_2

Vancouver

Kamudoni P, Johns N, Salek M-SS. Approaches to the Development and Use of PRO Measures: A New Roadmap. In Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Singapore: Adis. 2018. p. 15-49 https://doi.org/10.1007/978-981-10-8414-0_2

Author

Kamudoni, Paul ; Johns, Nutjaree ; Salek, Mir-Saeed Shayegan. / Approaches to the Development and Use of PRO Measures: A New Roadmap. Living with Chronic Disease: Measuring Important Patient-Reported Outcomes. Singapore : Adis, 2018. pp. 15-49

Bibtex

@inbook{de135b790d6d458e8d6f747d89b7c55a,
title = "Approaches to the Development and Use of PRO Measures: A New Roadmap",
abstract = "Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients{\textquoteright} role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new {\textquoteleft}gold standard{\textquoteright}.",
author = "Paul Kamudoni and Nutjaree Johns and Salek, {Mir-Saeed Shayegan}",
year = "2018",
month = sep,
day = "7",
doi = "10.1007/978-981-10-8414-0_2",
language = "English",
isbn = "978-981-10-8413-3",
pages = "15--49",
booktitle = "Living with Chronic Disease: Measuring Important Patient-Reported Outcomes",
publisher = "Adis",

}

RIS

TY - CHAP

T1 - Approaches to the Development and Use of PRO Measures: A New Roadmap

AU - Kamudoni, Paul

AU - Johns, Nutjaree

AU - Salek, Mir-Saeed Shayegan

PY - 2018/9/7

Y1 - 2018/9/7

N2 - Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

AB - Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

U2 - 10.1007/978-981-10-8414-0_2

DO - 10.1007/978-981-10-8414-0_2

M3 - Chapter

SN - 978-981-10-8413-3

SP - 15

EP - 49

BT - Living with Chronic Disease: Measuring Important Patient-Reported Outcomes

PB - Adis

CY - Singapore

ER -